Form 8-K - Current report:
SEC Accession No. 0001437749-25-035624
Filing Date
2025-11-18
Accepted
2025-11-18 17:16:58
Documents
13
Period of Report
2025-11-14
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20251118c_8k.htm   iXBRL 8-K 24197
  Complete submission text file 0001437749-25-035624.txt   142987

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxi-20251114.xsd EX-101.SCH 3581
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20251114_def.xml EX-101.DEF 10355
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20251114_lab.xml EX-101.LAB 13838
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20251114_pre.xml EX-101.PRE 10350
15 EXTRACTED XBRL INSTANCE DOCUMENT atxi20251118c_8k_htm.xml XML 2571
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 251495899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)